C3 invest £55k into developing better anti-TNF treatment algorithm’s

We have funded multiple studies run by the Exeter IBD and Pharmacogenetics Research Group – headed up by Dr Tariq Ahmad, Consultant Gastroenterologist at the Royal Devon and Exeter. Their work brings hope that personalised medicine is not too far into the future, and we want to help with these advancements which will allow the […]

Personalised anti-TNF therapy in Crohn’s disease study concludes

You may remember that we announced our £60,000 investment into the personalised anti-TNF therapy in Crohn’s disease study (PANTS), last year. Although anti-TNF drugs have given new hope for people with Crohn’s Disease and Ulcerative Colitis, and provided an important treatment option, they do not work in some patients. The research looked at the factors […]